Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|November 13, 2020
Synthesis of Conformationally Constrained d-Glu-meso-DAP Analogs as Innate Immune AgonistsSamo Guzelj, Žiga Jakopin
Frontiers in Pharmacology|August 8, 2022
Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer CellsSamo Guzelj, Žiga Jakopin
Biomolecules|August 26, 2022
Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual ScreeningSamo Guzelj, Tihomir Tomašič, Žiga Jakopin
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar PotencySamo Guzelj, Špela Bizjak, Žiga Jakopin
Bioconjugate Chemistry|October 10, 2024
Linker Chemistry and Connectivity Fine-Tune the Immune Response and Kinetic Solubility of Conjugated NOD2/TLR7 AgonistsŠpela Janež, Samo Guzelj, Žiga Jakopin
Journal of Medicinal Chemistry|November 6, 2022
Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune PotentiatorsSamo Guzelj, Matjaž Weiss, Bram Slütter, et al.
Pharmaceutics|December 23, 2022
Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant ActivitySamo Guzelj, Marcela Šišić, Špela Bizjak, et al.
Frontiers in Drug Delivery|August 21, 2025
Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccinesAllegra Peletta, Aurélie Marmy, Samo Guzelj, et al.
European Journal of Medicinal Chemistry|February 5, 2020
Structural features and functional activities of benzimidazoles as NOD2 antagonistsSamo Guzelj, Martina Gobec, Dunja Urbančič, et al.
Frontiers in Drug Delivery|August 21, 2025
Corrigendum: Preliminary results on novel adjuvant combinations suggest enhancement immunogenicity of whole inactivated pandemic influenza vaccinesAllegra Peletta, Aurélie Marmy, Samo Guzelj, et al.
Pageof 2